A Study to Evaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of Epilepsy
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to identify patient characteristics (such as baseline seizure
frequency) that may predict effective doses of topiramate using just that one drug
(monotherapy) as initial therapy for epilepsy. Topiramate is an anti-epileptic drug that is
approved for the treatment of epilepsy in adults and children 2 years of age and above.
Phase:
Phase 4
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.